Product Information
ATORVALIQ 20 MG/5 ML SUSP is a brand product labeled by CMP Pharma, Inc., priced at $1.1873 per ML under NDC 46287003001. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Feb 1, 2023.
Strength
20 mg/5mL
Manufacturer
CMP Pharma, Inc.NDC
46287003001
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
New Drug (NDA)
FDA Application
NDA213260FDA Approved
2/1/2023
On Market Since
3/1/2023
Pharmacological Classes
Price Statistics
The NADAC for ATORVALIQ 20 MG/5 ML SUSP has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 5.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1873 per ML |
|---|---|
| All-time high | $1.1908 (Feb 11, 2026) |
| All-time low | $1.1103 (Apr 23, 2025) |
| 52-week high | $1.1908 |
| 52-week low | $1.1450 |
| Median price | $1.1486 |
| Average price | $1.1544 |
| Largest weekly change | +4.0% (Oct 1, 2025) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ATORVALIQ market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ATORVALIQ 20 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for ATORVALIQ 20 MG/5 ML SUSP, manufactured by CMP Pharma, Inc., is $1.1873 per ML (NDC 46287003001), effective Aug 19, 2026.
How has the price of ATORVALIQ 20 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for ATORVALIQ 20 MG/5 ML SUSP has risen 5.9%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ATORVALIQ 20 MG/5 ML SUSP?
Since Apr 17, 2024, the NADAC for ATORVALIQ 20 MG/5 ML SUSP has ranged from a low of $1.1103 (Apr 23, 2025) to a high of $1.1908 (Feb 11, 2026), with a median of $1.1486 per ML.
Are there cheaper alternatives to ATORVALIQ 20 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of ATORVALIQ 20 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ATORVALIQ 20 MG/5 ML SUSP?
ATORVALIQ 20 MG/5 ML SUSP (NDC 46287003001) is labeled by CMP Pharma, Inc., and CMS classifies it as a brand product.